Clinical Effectiveness and Impact on Health-related Quality of Life in Peruvian Patients With Psoriasis After 16 Weeks of Adalimumab Therapy

Clinical trial NCT01156532 · TERMINATED

Trial details

NCT number: NCT01156532
Sponsor: AbbVie (prior sponsor, Abbott)
Status: TERMINATED
Study type: OBSERVATIONAL

Moderate to Severe Psoriasis

Start date: 2010-11-01
Primary completion: 2013-08-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.